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ApoptosisEmerging evidence suggests that activation of adenosine monophosphate-activated protein kinase (AMPK), an
energy gauge and redox sensor, controls the cell cycle and protects against DNAdamage. However, themolecular
mechanisms by which AMPKα isoform regulates DNA damage remain largely unknown. The aim of this study
was to determine if AMPKα deletion contributes to cellular hyperproliferation by reducing p21WAF1/Cip1 (p21)
expression thereby leading to accumulated DNA damage. The markers for DNA damage, cell cycle proteins,
and apoptosis were monitored in cultured mouse embryonic ﬁbroblasts (MEFs) isolated from wild type (WT,
C57BL/6J), AMPKα1, or AMPKα2 homozygous deﬁcient (AMPKα1−/−, AMPKα2−/−) mice by Western blot,
ﬂow cytometry, and cellular immunoﬂuorescence staining. Deletion of AMPKα1, the predominant AMPKα iso-
form, but not AMPKα2 in immortalized MEFs led to spontaneous DNA double-strand breaks (DSB) which
corresponded to repair protein p53-binding protein 1 (53BP1) foci formation and subsequent apoptosis. Further-
more, AMPKα1 localizes to chromatin and AMPKα1 deletion down-regulates cyclin-dependent kinase inhibitor,
p21, an important protein that plays a role in decreasing the incidence of spontaneous DSB via inhibition of cell
proliferation. In addition, AMPKα1 null cells exhibited enhanced cell proliferation. Finally, p21 overexpression
partially blocked the cellular hyperproliferation of AMPKα1-deleted MEFs via the inhibition of cyclin-
dependent kinase 2 (CDK2). Taken together, our results suggest that AMPKα1 plays a fundamental role in con-
trolling the cell cycle thereby affecting DNA damage and cellular apoptosis.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Several types of DNA damage, including oxidative damages,
depurinations, single-strand breaks (SSB), and DNA double-strand
breaks (DSBs), occur naturally during DNA replication [1]. DSBs are
among the most deleterious lesions in the genome, as it can cause
genomic rearrangements, chromosome breaks and translocations,
leading to apoptosis, senescence, or tumorigenesis [2]. Most DNA
damage can undergo DNA repair. For example, DSBs elicit a cascade
of protein recruitment to the chromatin surrounding DNA lesions
that regulate DNA damage response signaling and repair [3]. Cells re-
pair DSB by initiating either DNA nonhomologous end-joining (NHEJ),, adenosine monophosphate-
s, mouse embryonicﬁbroblasts;
icine, Department of Internal
ter, 941 Stanton L Young Blvd,
ax: +1 405 271 3973.a mutation-prone pathway [4,5], or homologous recombination (HR)
[6]. DSB repair by HR is largely error-free, as it employs undamaged
homologous sister chromatid DNA sequences as templates for repair
[2]. NHEJ is the prevalent DSB repair pathway in higher eukaryotes
[7]. Several molecules have been reported to be involved in DSB re-
sponse and repair. For example, p53-binding protein 1 (53BP1, also
known as TP53BP1) is a key effector of this DSB response [8,9], as it
promotes DNA damage repair by NHEJ [10–13].
Cyclin-dependent kinases (Cdks) play a pivotal role in the cell cycle.
Among them, Cdk2 is essential for G1/S phase transition and S phase
progression [14]. On the other hand, Cdk1 (formerly known as Cdc2)
associated with Cyclin B is essential for regulating cell cycle entry and
exits from mitosis [15,16]. In response to DNA damage, numerous cell
cycle signals are activated, which causes arrest in G1, thereby control-
ling progression through S phase and blocking entry into mitosis with
damagedDNA. For example, p21WAF1/Cip1 (p21) binds to and suppresses
Cdk2/cyclin E (CycE) complexes, thereby arresting cells at the G1/S
checkpoint [17]. In addition, p21 plays a fundamental role in DNA dam-
age response through inhibiting DNA synthesis via association and inhi-
bition of proliferating cell nuclear antigen (PCNA) [18]. Recently, it was
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mulation in leukemia stem cells [19].
The well-known energy sensor, adenosine monophosphate-
activated protein kinase (AMPK), consisting of a catalytic α subunit
(α1 or α2) and regulatory β (β1 or β2) and γ (γ1, γ2, or γ3) units,
also has a critical role in cell mitosis [20–22] and anti-oxidative stress
[23]. Emerging data indicate that AMPK plays an important role in
tumor suppression [24,25]. It was recently reported that AMPK regu-
lates UVB-induced DNA damage repair in skin tumor cells [26], as well
as playing a role in NHEJ via the LKB1-AMPK signaling pathway [27].
However, the exact role of the twoAMPKα isoforms and themechanism
by which AMPK might control the cell cycle and DNA damage remain
elusive. In this study,we address the involvement of AMPKα1 in cellular
hyperproliferation, DNA damage, and apoptosis by analyzing cell cycle
proteins and DNA damage markers in AMPKα1−/− mouse embryo
ﬁbroblasts (MEFs). We demonstrate here, for the ﬁrst time, that
AMPKα1−/−MEFs exhibit hyperproliferation, high levels of DNA DSB
markers, and consequent apoptosis, partially due to the p21 reduction.
Importantly, p21 overexpression decreased the foci formation of DSB
repair protein 53BP1 in AMPKα1−/−MEFs. These ﬁndings establish a
new role for AMPKα1 in cell cycle and DNA damage, providing novel
insights into the mechanism of tumor suppression mediated by AMPK.
2. Materials and methods
2.1. Materials and reagents
The following antibodieswere obtained fromCell Signaling Technol-
ogy (Beverly, MA): rabbit anti-AMPKα (2532), rabbit anti-phospho-
AMPKα (Thr172) (2535), rabbit anti-phospho-histone H3 (Ser10)
(9701), rabbit anti-phospho-p53 (Ser18) (9284), mouse anti-p53
(2524), rabbit anti-γ-H2AX (2577), anti-H2AX (2595), anti-phospho-
Chk1 (Ser345) (2348), rabbit anti-53BP1 (4937), rabbit anti-cleaved
caspase-3 (Asp175) (9664), rabbit anti-PARP (9542), rabbit anti-
phospho-Cdk2 (Thr160) (2561), rabbit anti-Cdk2 (2546), rabbit anti-
phospho-Cdk1(Thr161) (9114), and mouse anti-cyclin B1 (V152)
(4135). The following antibodies were purchased from Santa Cruz Bio-
technology (Santa Cruz, CA): goat anti-AMPKα1 (sc-19128), goat anti-
AMPKα2 (sc-19129), mouse anti-XRCC4 (sc-365118), mouse anti-p21
(sc-6246), mouse anti-GAPDH (sc-137179) and mouse anti-β-actin
(sc-47778). Caspase-3 inhibitor Z-DEVD-FMK (Cat. # FMK004) and
Caspase-9 inhibitor Z-LEHD-FMK (Cat. # FMK008) were purchased
from R&D Systems, Inc. Other chemicals and organic solvents of the
highest available grade were obtained from Sigma-Aldrich.
Ampkα1−/− and Ampkα2−/− mice were described elsewhere [28,29].
Mice were handled in accordance with study protocols approved by
the Institutional Animal Care and Use Committee of the University of
Oklahoma Health Sciences Center (Oklahoma City, OK).
2.2. Cell culture and transfection
Mouse embryonic ﬁbroblasts (MEFs) were isolated from
AMPKα1−/−, AMPKα2−/−, and WT embryos at 13.5-days post-coitus
and cells were immortalized by the 3T3 protocol as described previously
[30,31]. Brieﬂy, 13.5-day mouse embryo was decapitated, thoroughly
minced, and trypsinized. The dissociated cells were re-suspended. To
immortalize MEFs, cells were passaged continuously according to the
3T3 protocol (3 × 105 cells were plated per 60-mm dish every 3 days)
until growth rates in culture stabilized. Cells were then cultured for an
additional 15 passages (to about passage 35) and at that pointwere con-
sidered immortalized and used for experiments. MEFs weremaintained
in Dulbecco's modiﬁed Eagle's medium (Invitrogen, Carlsbad, CA) sup-
plemented with 10% FBS, L-Glutamine (2 mM) (Lonza, Walkersville,
MD), penicillin (100 μg/ml) (Life Technologies, Grand Island, NY). For
cell synchronization in G0/G1 phase, MEFs were serum starved, and
then re-incubated in complete medium for various times. MEFs weretransiently infected with LacZ, p21, or AMPKα1 adenovirus (MOI =
50) for 24 or 48 h as previously reported [32].
2.3. Indirect immunoﬂuorescence and microscopy
Cells were grown to exponential phase on poly-L-lysine-coated glass
coverslips. Cell were ﬁxed in 4% paraformaldehyde, permeabilized in
0.1% TritonX-100 and blocked with image-IT Fix or BSA (Invitrogen).
Primary antibodies used were: mouse anti-γ-H2AX (1:100 v/v) or rab-
bit anti-γ-H2AX (1:100 v/v), rabbit anti-53BP1, and mouse anti-p21.
DNA was stained with antifade reagent with 4′,6-diamidino-2-
phenylindole (DAPI) (Invitrogen, Carlsbad, CA). For indirect immuno-
ﬂuorescence, Alexa Fluor® 488 and 555 were used for detection of the
protein. Confocal microscopy was performed using a Zeiss 710 confocal
microscope (Oberkochen, Germany), with a 63× oil immersion lens.
Image editing was performed in Adobe Systems Incorporated, San
Jose, CA.
2.4. RNA extraction, cDNA synthesis, and real time PCR
Total mRNA was isolated and puriﬁed using the RNeasy mini kit
from Qiagen (Valencia, CA) according to the manufacturer's instruc-
tions. cDNA was synthesized from isolated mRNA using the iScript
cDNA synthesis kit (Bio-Rad Laboratories, Hercules, CA), as described
previously [29] and by the manufacturer's instructions. Real-time PCR
was performed on a ABI PRISM 7700 sequence detection system (Ap-
plied Biosystems) with SYBR green PCR master mix (Applied
Biosystems) and 1 μl of ﬁrst-strand cDNA as template with speciﬁc
primers for p21 (5′-CCTGGTGATGTCCGACCTGTT-3′, 5′-CCCCTTAGAA
GTCCGGCGAG-3′) [33]. The levels of gene expression were determined
relative to that of β-actin (5′-TGGGCCGCTCTAGGCACCA-3′, 5′- ACCGGA
ATCCCAAGTCCCC-3′).
2.5. Comet assay
Single cell DNA damage (double-stranded breaks) was analyzed
by neutral comet assay using the Trevigen's Comet Assay kit (4250-
050-K, Gaithersburg, MD) according to the manufacturer's instruc-
tion. Brieﬂy, cells were suspended in 0.7% low melting point agarose
and spread on glass slides precoated with 1% agarose. Slides were
overlaid with coverslips that were removed after the gel solidiﬁed.
The gel was treated with lysis solution (Trevigen) for 60 min at 4 °C
in the dark and electrophoresed at 1 V/cm for 20 min. Comet tails
were stained and slides were captured by ﬂuorescent microscope.
Quantitative measurements of DNA damage were performed by
using Comet Assay IV software (Perceptive Instruments).
2.6. Annexin V binding assay
Annexin V-FITC (Cat. # K101-100, BioVision, Milpitas, CA) was used
to detect the phosphatidylserine exposure to the outer surface of the
cell membrane by following the manufacturer's protocol. Brieﬂy, cells
were grown on cover slip in a 12 well plate with the desired treatment.
Cells werewashedwith PBS and 1× binding buffer, then incubatedwith
Annexin V-FITC (1:70 dilution) diluted in 1× binding buffer for 10 min.
Then cells werewashed twicewith 1× binding buffer and the coverslips
were mounted on microscope glass slides with Dako ﬂorescent mount-
ing medium. Randomly selected ﬁelds were counted using a ﬂuores-
cence microscope and quantitated using NIH Image software.
2.7. Flow cytometry analysis
Cells were serum starved for 24 h, then cultured in regular culture
medium for the indicated time. The treated cells were ﬁxed in 80%
ethanol and stained with 50 μg/ml propidium iodide (PI) in the pres-
ence of 10 μg of DNase-free RNase per ml [34]. Cell cycle proﬁles were
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analyzed using FCS Express V3 software. LacZ or p21 adenovirus-
infectedWT or AMPKα1−/−MEFswere serum-starved for 16h, then in-
cubated with regular culture medium plus 10 μMBrdU for 8 h. The cells
were harvested and ﬂow cytometric assay was performed by following
themanufacturer's protocol in BrdU Flow Kit (Cat. # 559619, BD Biosci-
ences, San Jose, CA). In addition, exponentially growing WT or
AMPKα1−/−MEFs were pulsedwith BrdU (10 μM) for 40min followed
bywasheswithwarmed serum-freemedium twice and re-feedingwith
warmed and pre-gassed whole medium. Cells were ﬁxed and stained
using the FITC BrdU Flow Kit after 0, 40 min, 2, 4, and 6 h post pulse.
The S and G2+Mphase durationswere calculated as previously report
[35].
2.8. Protein extraction, immunoprecipitation, and immunoblotting
Whole cell extracts were prepared using cell lysis buffer (9803)
from Cell Signaling Technology with protease and phosphatase in-
hibitor cocktails I and II (Cat. # BP-479 and BP-480, Boston
BioProducts, MA). Protein samples (30–50 μg) were separated by
SDS-PAGE, transferred onto nitrocellulose membranes, and probed
with different antibodies as previously described [36,37]. Following
incubation with the appropriate horseradish peroxidase-associated
secondary antibodies (Cell Signaling Technology), signals were
visualized with an enhanced chemiluminescence detection system
(GE Healthcare) and quantiﬁed by densitometry. Equal loading of
proteinwas veriﬁed by immunoblottingwith anti-β-actin or -GAPDH
antibody.A
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Fig. 1. AMPKα1 localizes to chromatin and is implicated in regulating the cell cycle. (A) MEF
AMPKα1, AMPKα2, AMPKα, p21, and 53BP1 were detected by Western blots. Histone H3 serv
loading control for each fraction. Representative data from three independent experiments a
serum-deprived for 24 h, then cultured in regular culture medium for the indicated times. T
−AMPKα1,−Cyclin B1,−pCdk1-T161, or pH3-S10 antibody. Representative data from thr
(two independent cell lines for each) were plated, and cells were counted at the indicated tim
and AMPKα1−/−MEFs serum starved for 24 h or treated with serum for the indicated times. n2.9. Subcellular fraction
Subcellular protein fractionation of cultured cells was performed as
described in the instructions for the commercial kit (Cat. # 78840,
Thermo Scientiﬁc, Rockford, IL).
2.10. Statistical analysis
Unless otherwise stated, data are presented as mean ± S.D. Differ-
ences between multiple means were evaluated by two-tailed
Student's t test or analysis of variance with post hoc Bonferroni cor-
rections. A p value b 0.05 was considered statistically signiﬁcant.
3. Results
3.1. Subcellular localization of AMPKα isoforms and dynamic activation of
AMPKα in MEFs
We examined the relative contribution of AMPKα1 and AMPKα2
isoform to total AMPKα in cytoplasmic and nuclear fractions. We per-
formed subcellular fractionation followed by immunoblotting to assess
the protein levels of AMPKα1, AMPKα2 and AMPKα in the cytoplasmic
and nuclear fractions. As expected, AMPKα1 and AMPKα2were not de-
tected in either cytoplasmic or nuclear fractions of AMPKα1−/− or
AMPKα2−/− MEFs, respectively (Fig. 1A). Since AMPKα1 is the pre-
dominant AMPKα isoform inMEFs [30], AMPKα1 deletion dramatically
decreased the cytoplasmic, nuclear soluble, and chromatin-bound
AMPKα (Fig. 1A), but increased AMPKα2 protein levels, which is inluble
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[38]. AMPKα1 and AMPKα2were predominantly found in the cytoplas-
mic region; however a small fraction of bothwere also located in the nu-
clear region (Fig. 1A). Both AMPKα1 and total AMPKα were almost
undetectable in the chromatin-bound and nuclear soluble fraction of
AMPKα1−/−MEFs (Fig. 1A). Interestingly, AMPKα1, but not AMPKα2
was chromatin-bound (Fig. 1A).
In WT MEFs, phosphorylated AMPKα on Thr-172 (pAMPKα-T172),
an indicator of active AMPKα [39], was higher with serum deprivation,
while AMPK activity was signiﬁcantly inhibited during serum stimula-
tion for 4–8 h (Fig. 1B). pAMPKα in WT MEFs was increased during
serum stimulation for 16 or 24 h, then decreased, which was consistent
with the upregulation of histone H3 phosphorylation at Ser10 (pH3-
S10) (Fig. 1B), a typical marker of cell mitosis [40]. Our data is in line
with previously published data demonstrating that AMPK activation is
dynamic during the cell cycle of HeLa cancer cells [22] and HEK293
cells [41]. However, AMPKα1 deletion showed higher levels of pH3-
S10 even under serum-free conditions, although pAMPKα was unde-
tectable. Taken together, these results imply that AMPKα1 might act
on chromatin and is required for normal cell cycle. Thus, loss of
AMPKα1 might lead to a dysregulated cell cycle in MEFs.3.2. AMPKα1 deletion enhances cell division in MEFs
It is reported that AMPK activation by glucose limitation sup-
presses cell-cycle progression via arresting the cell cycle at G0–G1
phase [42]. As depicted in Fig. 1C, AMPKα1 deletion signiﬁcantly ac-
celerated cell proliferation beginning at day 2 in culture comparedC
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vs WT. Representative images are shown in the upper panel.with WT MEFs. As calculated, the mean population doubling time of
AMPKα1−/− MEFs was around 18 h, while that of WT MEFs was
about 35 h. Furthermore, ﬂow cytometry data (Fig. 1D) demonstrated
that AMPKα1 deletion had less cells in G0/G1 phase (about 40%) com-
pared with WTMEFs (~92%) in response to serum starvation, howev-
er, AMPKα1−/−MEFs had more cells with S phase (about 55%) under
either serum-free or serum-stimulated conditions. AMPKα1 deletion
resulted in more cells in G2/M phase at 16 h after serum stimulation,
however, fewer cells were in G2/M phase at 24 h of serum stimulation.
Next, BrdU pulse-chase time course experiments demonstrated that
AMPKα1−/− MEFs had shorter S traverse time (4.5 ± 1.1 h) than
WT MEFs (11 ± 1.2 h). The G2/M phase traverse time (3.1 ± 0.4 h)
in AMPKα1−/− MEFs was also shorter than that (8.8 ± 0.9 h) in WT
MEFs. These results imply that AMPKα1−/− MEFs has reduced DNA
replication time. AMPKα1 deletion enhances cell cycle progression
from the G1 to S phase and G2 to M phase, which may be associated
with the persistently high levels of Cyclin B1 and phosphorylated
Cdk1 at T161 (Fig. 1B), an active form of Cdk1 [16,43].3.3. AMPKα1, not AMPKα2, deletion leads to increased DNA damage in
MEFs
Since AMPKactivation regulatesUVB-inducedDNAdamage repair in
skin tumor cells [26], we sought to identify whether AMPK regulates
DNA damage signaling in MEFs. As shown in Fig. 2A, AMPKα1, not
AMPKα2, deletion dramatically increased the protein level of serine
139-phosphorylated H2AX (γ-H2AX), an important and widely used
molecular marker for DNA DSB [6,44,45]. Furthermore, compared toAMPKα1-/-
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levels of serine-18 phosphorylation of p53, an indicator of DNA damage
associated with cellular apoptosis [30,46], as well as serine-345 phos-
phorylation of Chk1, a general DSB sensor and response effector [47].
The percentage of cells with greater than 7 γ-H2AX foci per cell were
markedly increased in AMPKα1−/− MEFs when compared with WT
and AMPKα2−/−MEFs (Fig. 2B). To further verify the spontaneous ac-
cumulation of DNA-strand breaks in the absence of AMPKα1, the neu-
tral comet assay was performed in both WT and AMPKα1−/−MEFs. In
agreement with the data above, the comet assay demonstrated that
AMPKα1 deletion exerts longer comet tails (Fig. 2C), which is closely as-
sociated with DNA damage [48]. These results suggest that AMPKα1
plays an important role in regulating DNA damage.3.4. AMPKα1 deletion-elevated DNA damage contributes to the increased
apoptosis
Sinceγ-H2AX induction and phosphorylation of p53 at S18 also exist
in apoptotic cells [49], it is important to validate whether the observed
increased γ-H2AX signal in AMPKα1-deleted MEFs is due to DNA dam-
age or apoptosis. As shown in Fig. 3, AMPKα1 deletion dramatically en-
hanced cell apoptosis as demonstrated by increased poly(ADP-ribose)
polymerase (PARP) cleavage (Fig. 3A and B) and Annexin V stainingBA
WT α1-/- WT α1-/-
Vehicle Cas-3i
γ-H2AX
Cleaved 
PARP
GAPDH
C
0
4
8
12
16
20
P
ro
te
in
 le
ve
ls
 
(fo
ld
 o
f  
W
T)
Vehicle Cas-3i
WT α1-/- WT α1-/-
Cleaved 
PARP
γ-H2AX
* *
†
#
C WT
Ve
hi
cl
e
AMPKα1-/-
C
as
-9
i
C
as
-3
i
Fig. 3. Increased DNA damage contributes to the elevated apoptosis in AMPKα1−/− ME
apoptosis in AMPKα1−/− MEFs, but had no effect on DNA damage signal as measured by
vs WT/Vehicle; # p b 0.01 vs α1−/−/Vehicle; *p b 0.001 vs WT/vehicle. (B) (Upper) Caspa
MEFs, but had no effect on DNA damage signal as measured by γ-H2AX expression. (Bott
vs α1−/−/Vehicle. (C) Representative images showing phosphatidylserine externalizatio
100 μm. (D) Quantiﬁcation of Annexin V intensity. n = 15, *p b 0.01 vs WT/Vehicle; †p b(Fig. 3C and D), which is consistent with a previous report [30]. The
treatment with Caspase-3 speciﬁc inhibitor Z-DEVD-FMK [50] signiﬁ-
cantly inhibited PARP cleavage and Annexin V staining (Fig. 3C and D),
but did not alter the γ-H2AX signaling (Fig. 3A). Moreover, the
Caspase-9 speciﬁc inhibitor Z-LEHD-FMK [51] clearly suppressed apo-
ptosis in AMPKα1−/− MEFs, indicated by the reduction of cleaved
PARP and Caspase-3 (Fig. 3B) and Annexin V staining (Fig. 3C and D),
however, the treatment had no effect on the elevated γ-H2AX
(Fig. 3B). These data indicate that γ-H2AX induction in AMPKα1−/−
MEFs is due to the increased DNA damage, which leads to the enhanced
apoptosis.3.5. Elevated DNA damage in AMPKα1−/− MEFs is partially due to p21
reduction
One possibility for the increased DNA damage seen in AMPKa1−/−
MEFs is the inability for the cell to activate DNA damage repair mecha-
nisms. Since 53BP1 plays critical roles in the repair of damaged DNA, we
investigated whether AMPKα1 deletion alters the protein levels of
53BP1. As depicted in Fig. 4A, AMPKα1 deletion did not change 53BP1
protein levels. Additionally, the amount of XRCC4, a DNA repair protein
[52], is similar between WT and AMPKα1−/−MEFs (data not shown).
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expression. Indeed, AMPKα1 deletion dramatically reduced total, cyto-
plasmic, chromatin-bound, and nuclear soluble p21 protein levels
comparedwithWT andAMPKα2 deletion (Figs. 4A and 1A). To examine
whether p21 protein reduction is due to increased protein degradation,
we treated cells with MG132, a potent inhibitor of the 26S proteasome
[53]. MG132 treatment did not reverse the p21 reduction in
AMPKα1−/− MEFs, whereas p21 protein levels in both WT and
AMPKα2−/− MEFs were signiﬁcantly increased (Fig. 4B), indicating
that the ubiquitin-proteasome system is not responsible for the p21
reduction in AMPKα1−/−MEFs. However, qRT-PCR assay demonstrated
that p21 mRNA levels were markedly down-regulated by AMPKα1
deletion compared with WT and AMPKα2 deletion (Fig. 4C). Overex-
pression of p21 for 48 h partially, but signiﬁcantly reduced γ-H2AX sig-
nal in AMPKα1−/−MEFs (Fig. 4D). These results suggest that AMPKα1
deletion impairs p21 transcription hence leading to increased DNA
damage which is partially rescued upon p21 overexpression.3.6. p21 inhibits 53BP1 foci formation
Next, we investigated whether p21 overexpression affects the foci
formation of repair protein 53BP1. The overall 53BP1 protein level was
similar in WT and AMPKα1−/− MEFs (Figs. 1A and 4A). InitialA BWT α1-/- α2-/-
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ﬁcation of Western blot data. n = 8, *p b 0.001 vs WT. (B) Proteasome inhibitor, MG132 (20
*p b 0.001 vs WT/vehicle or α2−/−/vehicle, respectively. (C) Quantitative RT-PCR analysis of p
of four independent experiments, *p b 0.001 vs WT. (D) p21 overexpression partially reduced
†p b 0.01 vs α1−/−/LacZ.qualitative assessment indicated that there was a stronger γ-H2AX sig-
nal in AMPKα1−/− MEFs compared to WT MEFs (Fig. 2A) which was
conﬁrmed by immunoﬂuorescence (Fig. 5A). No 53BP1 foci was ob-
served in about 85% ofWTMEFs, whichmay be due to less DNAdamage
(Figs. 5B and 2B). In contrast, 68% of AMPKα1−/−MEFs exhibited 53BP1
foci formation. p21 overexpression signiﬁcantly decreased 53BP1 foci
number in AMPKα1−/−MEFs, which is in line with the decreased foci
number of γ-H2AX. p21 did not show colocalization with 53BP1. Fur-
thermore, p21 overexpression did not alter the total 53BP1 protein
levels (Fig. 5D). In addition, AMPKα1 overexpression decreased DNA
damage in AMPKα1−/−MEFs as demonstrated by comet assay. These
results imply that p21 overexpression inhibits 53BP1 foci formation
highly associated with DNA damage [9] in AMPKα1-deleted MEFs.3.7. p21 overexpression partially abrogates the hyperproliferation and
apoptosis in AMPKα1−/−MEFs
Given the role of p21 in DNA repair and cell cycle regulation, we an-
alyzed whether p21 overexpression can normalize the phenotype of
AMPKα1−/− MEFs by evaluating cellular proliferation. As depicted in
Fig. 6A, p21 overexpression signiﬁcantly attenuated cell proliferation
of AMPKα1−/−MEFs, while only mildly inhibiting the proliferation of
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8 h. The ﬂow cytometric results indicated that deletion of AMPKα1 in-
creased the BrdU-positive cells by 6 times as compared with WT
(Fig. 6B), implying that there are more cells in S-phase for
AMPKα1−/−MEFs. Importantly, p21 overexpression signiﬁcantly de-
creased BrdU-positive cells in AMPKα1−/−MEFs by 46%, as compared
to LacZ infection (Fig. 6B). Furthermore, the CDK2 phosphorylation at
T160, an active form of CDK2 [54], in AMPKα1−/−MEFs, was markedly
ablated byp21 overexpression (Fig. 6C). In addition, the apoptotic signal
in AMPKα1−/−MEFs was profoundly blunted by p21 overexpression
(Fig. 6D).
4. Discussion
In the present study, we have demonstrated that AMPKα1, but not
AMPKα2 deletion, mediates aberrant cell proliferation, spontaneous
DNA DSB damage, and apoptosis in MEFs. The mechanism underlying
this process is partly due to p21 reduction. The enhanced cell prolifera-
tion in AMPKα1−/−MEFs is due to the G1 to S transition and impaired
G2/M arrest resulting from activation of Cdk2 and Cdk1 by p21 reduc-
tion. p21 overexpression decreases 53BP1 foci formation in AMPKα1-
deleted MEFs. These ﬁndings indicate that AMPKα1 is a pivotal regula-
tor for cell cycle, DNA DSB and resultant apoptosis.
A previous report indicated that AMPKα is associated with the efﬁ-
cient repair of UVB-induced DNA damage in SKH-1 mouse skin, via
the regulation of xeroderma pigmentosum group C (XPC) [26], a crucial
initiator of global genome nucleotide excision repair [55]. Here, we
have, for the ﬁrst time, demonstrated that AMPKα1 isoform deletion
down-regulated p21 and transient overexpression of p21 partially re-
duced this DNA damage (Figs. 4D and 5A), suggesting that p21 mayplay an integral part in DNA damage and repair. Recently, it is reported
that p21 inhibits DNA damage through interaction with PCNA [18].
These results are consistent with the ﬁndings in leukemia stem cells
[19]. Furthermore, a critical and previously unrecognized role of p21
as a gatekeeper of AMPKα1 deletion-inducedDNAdamagewas demon-
strated. p21 overexpression decreased 53BP1 foci formation in
AMPKα1-deﬁcient cells via an unknown mechanism. How 53BP1 is re-
cruited to DSB sites has been recently studied. Histonemodiﬁcations are
involved in 53BP1 recruitment to DSB sites [10]. Our data imply that p21
may be an additional 53BP1 effector. In addition, p21 reduction in
AMPKα1-deleted MEFs is unlikely p53-dependent, a widely reported
molecular mechanism [56–59], since p53 is up-regulated by AMPKα1
deletion (Fig. 2A). Hence, the mechanism involved in p21 reduction by
AMPKα1 deletion or inhibition warrants further investigation.
Increasing evidence indicates that AMPK controls the cell cycle [29,
60] andmitosis [20–22] via distinctmechanisms. For example, constitu-
tive expression of AMPK-related kinase NUAK1 leads to gross aneu-
ploidies in WI-38 human ﬁbroblast [61]. Additionally, p21 is required
for proper cell cycle control and consequent chromosome stability in
Trp53 515C/515C mice (encoding p53R172P, the corresponding murine
p53 mutant) which is deﬁcient for apoptosis but retains a partial cell
cycle arrest function [62]. Unrepaired DNA damage is a trigger for cellu-
lar apoptosis and/or enhanced cell proliferation [63], and AMPKα1 dele-
tion enhances MEFs apoptotic signaling [30]. Here, AMPKα1 deletion
increased Cdk2 protein levels and decreased p21, as well as stimulated
cell proliferation. p21 overexpression partially inhibited Cdk2 phos-
phorylation at T160 and consequently hindered cell hyperproliferation
and the resultant DNA damage. In addition, p21 overexpression partial-
ly suppressed apoptosis in AMPKα1−/−MEFs, which is due to the in-
creased DNA damage.
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72 H. Xu et al. / Biochimica et Biophysica Acta 1853 (2015) 65–73Loss of AMPKα1 culminates in elevated DNA damage, which
when prolonged can lead to accumulation of a lethal amount of dam-
aged DNA or mutated DNA, thereby resulting in apoptosis or
hyperproliferation associated with cancer development. As AMPK
is an important modulator of cell metabolism, it will be interesting
to examine whether AMPKα1 regulates DNA damage, in part via
modulating fuel switching.
In summary, our studies reveal an important role for AMPKα1 in cell
biology and connect two hallmarks of tumor cells: hyperproliferation
and DNA damage [64–66], which may be due to p21 reduction. Given
the importance of AMPK in the cell cycle, these ﬁndings hold profound
implications for understanding the molecular mechanisms by which
AMPK functions as a promising tumor suppressor or senescence
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